We are live on ! Find out more
SG

StepStone Group Portfolio holdings

AUM $207M
1-Year Est. Return 12.33%
This Fund
S&P 500
This Quarter Est. Return
+15.07%
1 Year Est. Return
-12.33%
3 Year Est. Return
+92.06%
5 Year Est. Return
+17.44%
10 Year Est. Return
+217.33%
AUM
$493M
AUM Growth
+$21.5M
Cap. Flow
-$8.94M
Cap. Flow %
-1.81%
Top 10 Hldgs %
98.67%
Holding
23
New
2
Increased
–
Reduced
–
Closed
7

Top Buys

Rank Stock Value
1
SEMR
Semrush
SEMR
+$650K
2
FINV
FinVolution Group
FINV
+$257K

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$5.68M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$2.5M
3
NU icon
Nu Holdings
NU
+$790K
4
CFLT
Confluent
CFLT
+$397K
5
BASE
Couchbase
BASE
+$228K

Sector Composition

Rank Sector Weight
1 Financials 49.03%
2 Technology 32.81%
3 Industrials 8.13%
4 Healthcare 6.38%
5 Communication Services 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNB
1
DELISTED
Dun & Bradstreet
DNB
$192M 38.95%
20,742,226
– –
WKME
2
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$145M 29.37%
10,366,855
– –
ML
3
DELISTED
MoneyLion Inc.
ML
$45.8M 9.29%
622,931
– –
RKLB icon
4
Rocket Lab Corp
RKLB
$42.3B
$39.4M 7.99%
8,206,916
– –
RBLX icon
5
Roblox
RBLX
$37B
$17.4M 3.52%
466,666
– –
PATH icon
6
UiPath
PATH
$6.3B
$16.3M 3.31%
1,286,527
– –
HLVX
7
DELISTED
HilleVax
HLVX
$12M 2.42%
826,569
– –
TRDA icon
8
Entrada Therapeutics
TRDA
$267M
$10.8M 2.2%
761,277
– –
PHAT icon
9
Phathom Pharmaceuticals
PHAT
$873M
$4.35M 0.88%
422,085
– –
DOMA
10
DELISTED
Doma Holdings, Inc.
DOMA
$3.61M 0.73%
595,180
– –
NEUE
11
DELISTED
NeueHealth
NEUE
$2.86M 0.58%
525,250
– –
TNYA icon
12
Tenaya Therapeutics
TNYA
$177M
$1.43M 0.29%
462,163
– –
VCSA
13
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$717K 0.15%
147,261
– –
GROV icon
14
Grove Collaborative
GROV
$45.4M
$673K 0.14%
380,383
– –
SEMR
15
DELISTED
Semrush
SEMR
$628K 0.13%
+46,875
New +$650K
FINV
16
FinVolution Group
FINV
$1.12B
$251K 0.05%
+52,521
New +$257K
AMPL icon
17
Amplitude
AMPL
$1.27B
– –
-2,793
Closed -$30.4K
BASE
18
DELISTED
Couchbase
BASE
– –
-8,652
Closed -$228K
CFLT
19
DELISTED
Confluent
CFLT
– –
-13,024
Closed -$397K
CRWD icon
20
CrowdStrike
CRWD
$207B
– –
-2,688
Closed -$215K
NU icon
21
Nu Holdings
NU
$65.6B
– –
-66,210
Closed -$790K
HCP
22
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-210,840
Closed -$5.68M
NGM
23
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-1,573,357
Closed -$2.5M

Similar funds

SNBOSD
Security National Bank of So Dak Sioux City, Iowa $207M AUM 21.03% 1-Year Est. Return
MPCG
Matrix Private Capital Group New York $207M AUM 16.87% 1-Year Est. Return
BWM
Birchcreek Wealth Management Miami Township, Ohio $208M AUM 18.75% 1-Year Est. Return
HCA
Hyperion Capital Advisors New York $208M AUM 10.31% 1-Year Est. Return
KIC
Kensington Investment Counsel Long Beach, California $208M AUM 11.99% 1-Year Est. Return
CC
CIBRA Capital London, United Kingdom $207M AUM
JWM
Johnson Wealth Management Grand Forks, North Dakota $207M AUM
PM
Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return

StepStone Group's Q2 2024 Portfolio in Review

As of Q2 2024, StepStone Group held 23 positions worth $493M, up 4.6% from $472M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

StepStone Group's Q2 2024 filing shows 2 new and 7 closed positions. Its largest new stake was Semrush: 46,875 shares worth $628K. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $5.68M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

  • StepStone Group's largest Q2 2024 buy was Semrush: 46,875 shares worth $628K.
  • StepStone Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $5.68M.
  • StepStone Group's ten largest holdings make up 99% of its $493M portfolio in Q2 2024.
  • StepStone Group opened 2 new positions and closed 7 in Q2 2024.
  • StepStone Group's portfolio value rose 4.6% quarter-over-quarter to $493M.

Based on StepStone Group's 13F filing for Q2 2024, filed 14 Aug 2024.